Insiders Avacta Group Plc

Equities

AVCT

GB00BYYW9G87

Biotechnology & Medical Research

Delayed London S.E. Other stock markets 12:05:25 08/06/2026 BST			5-day change	1st Jan Change
69.95 ^GBX	-2.17%		-5.48%	+20.60%

06-05	Avacta Group raises GBP9 million for bond repayments	AN
06-05	Avacta Therapeutics Raises GBP9 Million from Share Issue	MT

Insiders

05-29	Avacta Group plc Announces Board Changes	CI
03-27	Avacta raises GBP10 million in equity for clinical tests	AN
02-09	Avacta appoints new chief scientific officer, plans clinical trials	AN
02-09	Avacta Therapeutics Names Chemistry Vice President as Chief Scientific Officer	MT
02-09	Avacta Therapeutics Announces Executive Changes	CI
01/07/25	EXECUTIVE CHANGES: Avacta names CMO, Mission Group appoints CEO	AN
01/07/25	Avacta Group Names Chief Medical Officer	MT
01/07/25	Avacta Group plc Appoints David Liebowitz as Chief Medical Officer	CI
06/06/25	Avacta Group Plc Announces Board Appointments	CI
29/04/25	Avacta Group plc Announces Changes to Its Board, Effective Date Is April 30, 2025	CI
13/01/25	Britain's Avacta Recruits New CFO	MT
13/01/25	Avacta Appoints Brian Hahn Chief Financial Officer	CI
15/10/24	Avacta Group Names Chief Scientific Officer	MT
15/10/24	Avacta Group plc Appoints Michelle Morrow as Chief Scientific Officer, Effective November 4, 2024	CI
26/06/24	Avacta Group plc Announces Board Changes	CI
20/06/24	Avacta Appoints New Nonexecutive Chairman	MT
20/06/24	Avacta Group plc Announces Board Changes	CI
01/05/24	Avacta picks Christina Coughlin to replace long-serving CEO	AN
30/04/24	Avacta Group CEO Steps Down; Successor Appointed	MT
30/04/24	Avacta Group plc Announces Chief Executive Officer Changes	CI
19/01/24	Avacta says new head of R&D Coughlin brings "deep expertise"	AN
19/01/24	Avacta Group plc Announces Appointment of Christina Coughlin as Head of Research and Development and Resignation of Fiona Mclaughlin as Chief Scientific Officer	CI
19/12/23	Avacta taps biopharma veteran as Therapeutics business chief	AN
19/12/23	Avacta Group plc Appoints Simon Bennett as Chief Business Officer of the Therapeutics Division	CI
20/09/23	Avacta Group Plc Announces Management Changes	CI